By Prenetics

Our mission

To collect 1,000,000 samples from across the African continent and create a "one-of-a-kind" African biobank.


Why do we need Black DNA?

Medical research relies heavily on the use of human DNA to test and research the efficacy of new medicines. 99% of this DNA is from white European descendants compared with 17% of the global population of Black people from an African lineage. This means that much of existing medicine doesn’t often work on those African descendants, or worse, causes additional deaths in some cases.

Disease and medicine in Africans

Average life expectancy in Africa is 20 years below that of the UK

Africa currently carries 25% of the global disease burden

Many treatments for infectious diseases in Africans cause Adverse Drug Reactions (ADRs)

Hospital admissions due to ADRs are 3x higher in Africa compared to the West

Real-life examples of adverse drug reactions

Depression and suicide

20% of Zimbabweans and 13.5% of people from Botswana were found to have a genetic variant that slows the breakdown of Efavirenz. This variant causes the drug to accumulate in the bloodstream, leading to hallucinations, depression and suicidal tendencies.

Codeine ban

Ethiopia banned the use of codeine because a high proportion of its people carry a gene variant that causes them to rapidly convert the drug into morphine, which can cause breathing problems or even death.

Albuterol issues

A set of genetic mutations found mostly in people of African ancestry may make them less likely to respond to Albuterol — the most prescribed asthma drug in the world.

Our solution

Creating a biobank and building a solution for a healthier world.

Better data, better research

This initiative will help develop the world’s most powerful medical dataset, which will unlock priceless value in the advancement of medical research. The most immediate opportunity is to piggyback on the widespread testing of COVID-19 in South Africa.

World-beating medicine

This biobank will play a critical role in propelling us towards precise and personalised healthcare that’s driven by a more inclusive and comprehensive knowledge of our genome. As a result, Black people will have medicines that are both safe and suited to their genetics.

Britain and South Africa agree health partnership on second day of state visit

Britain and South Africa on Wednesday 23rd November 2022 announced a new health and science partnership to mark the second day of President Cyril Ramaphosa's state visit to The United Kingdom, the first such official guest hosted by Britain's King Charles.

King Charles, 74, who rolled out traditional pomp and ceremony to welcome President Ramaphosa also hosted a banquet in his honour on Tuesday. Ramaphosa also addressed lawmakers at the Houses of Parliament.

Read more

Joe Mojapelo, CEO of the The African Institute of Everyone Genome (AiEG)

Why must we act now?

Africa has the fastest growing population of any continent

The population is expected to represent 33% of the world’s population by 2100

50% of Africa’s population are under the age of 18

There are an estimated 172 million African diaspora around the world

Why Black DNA Matters

Healthcare is a fundamental human right. In an increasingly connected and globalized world, no one should have to suffer from diseases that modern medicine can treat. So, the stark differences caused by a lack of access to quality healthcare for Africans compared to the rest of the world - need to be addressed. Currently, not all healthcare is created equal.


© 2020 Everyonegenome | All rights reserved | Website by Hix